Regarding the use of COR as a modulator of antitumor immunity, Deng et al. (2022) demonstrated in a murine model of colon cancer that COR can increase the infiltration of CD4+ and CD8+ T lymphocytes, NK cells, and a higher proportion of macrophages with an M1 phenotype. This evidence concerns the gene CD8A and malignant colon neoplasm.